mirzaten q-tab 30 mg
krka, d.d., novo mesto, slovinsko - mirtazapín - 30 - antidepressiva
mirzaten q-tab 45 mg
krka, d.d., novo mesto, slovinsko - mirtazapín - 30 - antidepressiva
azibiot neo 40 mg/ml prášok na perorálnu suspenziu
krka, d.d., novo mesto, slovinsko - azitromycín - 15 - antibiotica (proti mikrob. a vÍrusovÝm infekciam)
azibiot neo 20 mg/ml prášok na perorálnu suspenziu
krka, d.d., novo mesto, slovinsko - azitromycín - 15 - antibiotica (proti mikrob. a vÍrusovÝm infekciam)
flixonel 50 mikrogramov/dávka
glaxosmithkline consumer healthcare czech republic s.r.o., Česká republika - flutikazón - 69 - otorhinolaryngologica
sumamed forte
teva pharmaceuticals slovakia s.r.o., slovensko - azitromycín - 15 - antibiotica (proti mikrob. a vÍrusovÝm infekciam)
sumamed 500 mg
teva pharmaceuticals slovakia s.r.o., slovensko - azitromycín - 15 - antibiotica (proti mikrob. a vÍrusovÝm infekciam)
zigilex orotab 100 mg
pharmaswiss Česká republika s.r.o., Česká republika - azitromycín - 15 - antibiotica (proti mikrob. a vÍrusovÝm infekciam)
sarclisa
sanofi winthrop industrie - isatuximab - viacnásobný myelóm - antineoplastické činidlá - sarclisa is indicated: in combination with pomalidomide and dexamethasone, for the treatment of adult patients with relapsed and refractory multiple myeloma (mm) who have received at least two prior therapies including lenalidomide and a proteasome inhibitor (pi) and have demonstrated disease progression on the last therapy. in combination with carfilzomib and dexamethasone, for the treatment of adult patients with multiple myeloma who have received at least one prior therapy (see section 5.